Health Care & Life Sciences » Biotechnology | BioTie Therapies Oyj

BioTie Therapies Oyj

BioTie Therapies Oyj
Stock Exchange Other OTC
EPS
-
Market Cap
-
Shares Outstanding
1.09 B
Public Float
-

Profile

Address
420 Saw Mill River Road
Ardsley New York 10502
United States
Employees -
Website http://www.acorda.com
Updated 09/14/2018
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury.

Financials

View All
Created with Highcharts 5.0.14BioTie Therapies OyjNet Income. Fiscal year is January-December. All values USD Thousands.16 44116 44117 67217 67211 05811 05834 61834 618223 359223 35920132014201520162017050k100k150k200k250k
Created with Highcharts 5.0.14BioTie Therapies OyjSales/Revenue. Fiscal year is January-December. All values USD Thousands.336 430336 430401 480401 480492 660492 660519 601519 601588 287588 287201320142015201620170100k200k300k400k500k600k700k

Ronald Cohen
President, Chief Executive Officer & Director
Catherine D. Strader
Independent Director